Clinical characteristics of Crohn’s disease (CD) patients.

*Total is higher than the number of patients as some of them receive combination of medication.**mAb: Monoclonal antibody. All patients, except two in the active CD patients group failing adalimumab therapy at the time of inclusion, received infliximab.***Except ileocolonic resection no patient had underwent other type of small bowel and/or colonic surgery.